The Food and Drug Administration (FDA) has recently introduced a new framework for the review of animal food ingredients through the Animal Food Ingredient Consultation (AFIC) program, as outlined in Guidance for Industry (GFI) 294. This regulatory change signifies a significant shift in the oversight of animal food, providing a streamlined pathway for animal food innovators to bring safe ingredients to market.

The AFIC program replaces the longstanding FDA-AAFCO pathway, which ceased on October 1, 2024. This change eliminates one of the industry’s primary regulatory pathways, which was commonly utilized by ingredient innovators. The FDA has established the AFIC program with the aim of reducing delays in the approval process, minimizing gaps in ingredient reviews, and establishing consistent standards to prevent disruptions in the market.

Under GFI 294, ingredient innovators now have a structured pathway to consult with the FDA to ensure that safety standards are met before market entry. This program allows animal food innovators to engage with the FDA and provide data demonstrating the safety of their ingredients. The guidance outlines submission requirements, specifying the type of data needed for FDA evaluation and detailing the agency’s role in assessing this information to address industry concerns.

The AFIC program represents a more efficient and transparent process for the review of animal food ingredients, offering a clear pathway for innovators to navigate the regulatory landscape. By providing a direct line of communication with the FDA and outlining specific submission requirements, the program aims to facilitate the timely approval of safe ingredients for use in animal food products.

The implementation of GFI 294 and the AFIC program mark a significant milestone in the regulation of animal food ingredients, signaling a shift towards a more streamlined and responsive regulatory framework. By offering a structured pathway for ingredient consultation and review, the FDA aims to promote innovation in the animal food industry while ensuring the safety and quality of ingredients available on the market.

Overall, the introduction of the AFIC program under GFI 294 represents a positive step towards enhancing the regulatory process for animal food ingredients. By providing a clear pathway for ingredient innovators to consult with the FDA and demonstrate the safety of their products, the program aims to foster innovation and ensure the availability of safe and high-quality ingredients for use in animal food products.

In conclusion, the establishment of the AFIC program under GFI 294 reflects the FDA’s commitment to promoting innovation and safety in the animal food industry. By providing a structured pathway for ingredient review and consultation, the program aims to streamline the regulatory process and ensure the availability of safe and effective ingredients for use in animal food products.